# q06 rev 0 raw returns (tested_sha256 75af3300481645edaf27d664082704af6e30b89f9562705829b7ca01289349f2)

Fresh agents dispatched 2026-10-06 by the caller (Claude Code, Opus 5.5) with only the workspace
root, their own packet path and the verbatim question (closed-book: question only). Returns are
copied verbatim from the task notifications.

## Blind solver A (blind-solver, packet solver-1)

I found the answer directly in the documents: the low end moved by **−$0.17**, from $5.55 to $5.38.

answer: −$0.17 (the low end fell from $5.55 to $5.38)

confidence: high

path:
1. **Completion date.** Abbott completed the Exact Sciences acquisition on March 23, 2026.
   - D08 (Apr 16, 2026 release), line 27: "On March 23, 2026, Abbott completed its acquisition of Exact Sciences".
   - D10, line 685, says the same: "Exact Sciences was acquired by Abbott on March 23, 2026."
2. **Range on March 23, 2026.** The range in effect was the one issued January 22, 2026.
   - D07, line 31: "Abbott projects full-year 2026 adjusted diluted EPS of $5.55 to $5.80". Line 335 repeats it in the guidance section.
   - D07, line 33, still expected the deal to close "in the second quarter of 2026", so this range was set before the acquisition.
   - No packet document dated between Jan 22 and Apr 16, 2026 changes it. The next guidance release is D08, headlined "Updates Guidance to Reflect Acquisition of Exact Sciences" (line 15).
3. **Range on June 30, 2026.**
   - D08, line 223: "Abbott projects full-year 2026 adjusted diluted earnings per share of $5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact Sciences."
   - D10 (Jul 16, 2026), line 29, shows that range was still standing until mid-July: "Abbott raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to previous range of $5.38 to $5.58."
   - That raise came after June 30, so it falls outside the window.
4. **Calculation.** $5.38 − $5.55 = −$0.17, a decrease of 17 cents. For comparison, the high end moved $5.58 − $5.80 = −$0.22.

minimal_documents: D07 + D08. D10 is a partial substitute for D08: it gives the March 23 close date and the "previous range of $5.38 to $5.58" that stood until July 16. It does not show when that range was set, so D08 is the cleaner choice. D10 is also useful to confirm nothing changed between April 16 and June 30.

readings:
- **Main reading.** Compare the range in effect on March 23 (the January range) with the range in effect on June 30 (the April range): −$0.17.
- **Earliest post-close range as the start point.** If you count from the first range issued after the close (April 16, $5.38), the change to June 30 is $0.00. This doesn't fit the wording well, because on March 23 itself the January range was still in effect.
- **Excluding the acquisition dilution.** Adding back the stated $0.20 Exact Sciences dilution gives a low end of $5.58, or +$0.03 against $5.55. The question asks about the published guidance range, so this is only background.
- **Using the July raise (wrong date).** Taking the July 16 low end of $5.45 instead would give −$0.10, but that raise came after June 30.

gaps: none material.
- All documents are plain text, not PDFs, and there are no layout files, so I had no extraction issues or charts to check.
- I read D07 (lines 1–50 and 320–364), D08 (lines 1–280), D09 in full (a court notice about a shareholder derivative-suit settlement, no guidance) and D11 in full (an NEC litigation release, no guidance). I checked the start of D06, which is Abbott's by-laws.
- I did not read D01–D05 or D10 in full. Searches across them for 2026 EPS or guidance wording and for the figures $5.38, $5.45, $5.55, $5.58, $5.60 and $5.80 found matches only in D07, D08 and D10. D05 (the November 2025 deal announcement) has no EPS guidance.
- The packet can't rule out a guidance change outside these documents, for example on March 23 itself or during May–June. However, D10's "previous range of $5.38 to $5.58" confirms nothing changed between April 16 and July 16.
- I did not read question.txt.

contaminated: no

Relevant files (packet root `D:\Dev\Docket\tasks\aq-00745\runs\q06-r0-v2-75af3300481645edaf27d664082704af6e30b89f9562705829b7ca01289349f2\solver-1`):
- `text\D07.txt`
- `text\D08.txt`
- `text\D10.txt`
- `text\manifest.json`

## Blind solver B (blind-solver, packet solver-2)

**answer:** −$0.17. The low end fell from $5.55 to $5.38.

**confidence:** high

**path:**
1. **Acquisition date (D08, line 27):** "On March 23, 2026, Abbott completed its acquisition of Exact Sciences". D10 lines 49 and 685 give the same date.
2. **Guidance in effect on March 23, 2026 (D07, Jan. 22, 2026, lines 31 and 335):** "Abbott projects full-year 2026 adjusted diluted earnings per share of $5.55 to $5.80". D07 line 33 says the company "continues to expect the transaction to close in the second quarter of 2026." No packet document shows any guidance change between January 22 and April 16. The next update is D08, whose headline (line 15) reads "Updates Guidance to Reflect Acquisition of Exact Sciences". So the low end on March 23 was **$5.55**.
3. **New guidance after the close (D08, Apr. 16, 2026, line 223):** "Abbott projects full-year 2026 adjusted diluted earnings per share of $5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact Sciences."
4. **Still in effect on June 30, 2026 (D10, July 16, 2026, line 29):** "Abbott raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to previous range of $5.38 to $5.58." The raise came on July 16, after June 30. The "previous range" wording shows nothing changed between April 16 and July 16. So the low end on June 30 was **$5.38**.
5. **Calculation:** $5.38 − $5.55 = **−$0.17**, a decrease.

**minimal_documents:**
- **D07:** the guidance in effect at closing.
- **D08:** the closing date and the April 16 update.
- **D10:** confirms $5.38–$5.58 was still the range until July 16, after June 30. It also gives the closing date.

No replacement exists:
- D10 alone does not say when the $5.38–$5.58 range was issued, so D08 is needed.
- No other document gives the January range.

**readings:**
- **July 16 range:** D10 reports the quarter ended June 30, but it was issued July 16. Using its $5.45 low end gives $5.45 − $5.55 = −$0.10. I reject this because that range was not in effect on June 30.
- **Starting from the April 16 range:** Treating the first guidance that reflected the acquisition ($5.38) as the starting point gives $0.00. I reject this because the question anchors on the closing day, March 23, when $5.55 was in effect.
- **Excluding the acquisition's EPS dilution:** Adding back the stated $0.20 of dilution puts the low end at $5.58, or +$0.03 versus $5.55. The question asks about the stated range, so this is not the answer.

**gaps:**
- No packet document is dated March 23, 2026. "No guidance change on the closing day" is inferred from D08's "Updates Guidance" headline and from the absence of any other update. No document directly confirms it.
- The packet has no investor-conference or other mid-quarter guidance statements. D10's "previous range" wording covers April 16 to July 16.
- **Coverage:**
  - Read fully or in the relevant sections: D07, D08, D09, D10 and D11.
  - Partly read: D05 (the November 2025 deal announcement, which gives no EPS guidance) and D06 (only its opening, which identifies it as the by-laws).
  - Grep only: D01–D04, which contain FY2025 guidance.
- The manifest lists all documents as text with no PDF pages, and there are no layout files, so I inspected no PDFs.

**contaminated:** no

Files used:
- `D:\Dev\Docket\tasks\aq-00745\runs\q06-r0-v2-75af3300481645edaf27d664082704af6e30b89f9562705829b7ca01289349f2\solver-2\text\D07.txt`
- `D:\Dev\Docket\tasks\aq-00745\runs\q06-r0-v2-75af3300481645edaf27d664082704af6e30b89f9562705829b7ca01289349f2\solver-2\text\D08.txt`
- `D:\Dev\Docket\tasks\aq-00745\runs\q06-r0-v2-75af3300481645edaf27d664082704af6e30b89f9562705829b7ca01289349f2\solver-2\text\D10.txt`

## Closed-book solver (question only, no tools used)

answer: -$0.17 (I think the low end fell from $5.55 to about $5.38)

confidence: low

basis: From memory, Abbott's January 2026 full-year guidance for adjusted diluted EPS was $5.55 to $5.80, and it left out the Exact Sciences deal. I believe the deal closed in the first quarter of 2026, before the April results, so the $5.55 low end would still have applied on the closing day. I don't reliably remember the April 2026 update that added the Exact Sciences dilution. The $5.38 low end is my estimate based on dilution of roughly $0.20. The real low end could plausibly be $5.35 or $5.40, which would make the change -$0.20 or -$0.15.

contaminated: no (only an automatic note with the user's email address was attached)

## Shortcut auditor (shortcut-auditor, packet shortcut)

answer: −$0.17. The low end fell from $5.55 to $5.38.

verdict: clear

shortest_path:
1. **Closing date.** D08 (Apr 16, 2026), line 27: "On March 23, 2026, Abbott completed its acquisition of Exact Sciences". D08 line 137 and D10 line 203 say the same.
2. **Range in effect on Mar 23, 2026.** D07 (Jan 22, 2026), lines 31 and 335: "Abbott projects full-year 2026 adjusted diluted earnings per share of $5.55 to $5.80". D07 line 33 says the deal was still expected "to close in the second quarter of 2026", and that guidance did not reflect the deal. D08's title, "Updates Guidance to Reflect Acquisition of Exact Sciences", shows the January range stood until April 16. No packet document between Jan 22 and Apr 16 changes 2026 guidance. Low end: $5.55.
3. **Range in effect on Jun 30, 2026.** D08 lines 19, 31 and 223: "$5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact Sciences". D10 (Jul 16, 2026), line 29, confirms this range lasted until mid-July: "raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to previous range of $5.38 to $5.58." Low end: $5.38.
4. **Calculation.** $5.38 − $5.55 = −$0.17. For reference, the high end moved $5.80 → $5.58 (−$0.22).

sufficient_documents:
- Minimal set: D07 + D08. D08 gives the closing date and the April range; D07 gives the January range.
- Alternative: D07 + D10. D10 gives the closing date and, as the "previous range", the range in effect on June 30.
- No single document works. Only D07 contains $5.55/$5.80, and it has no closing date or later range. D08 and D10 never state the January range. "0.17" appears nowhere in the packet.

searches:
- Literal searches: "Exact Sciences"; complete/closed…acqui; projects/guidance/outlook…EPS; "full-year 2026"; 5.55, 5.80, 5.38, 5.58, 5.45, 5.60; previous, reaffirm, raises, narrow, "updat… guidance", 0.17, "17 cents"; EPS, dilut, accretive and "expected to close" in D05; 2026 guidance in D01–D06.
- Sources inspected: manifest; D07, D08 and D10 (headlines and guidance sections); D05 (deal announcement: closing expected Q2 2026, no EPS figure); D09 (derivative-settlement notice, Apr 17, 2026); D11 (preterm-formula litigation settlement, Aug 20, 2026); D06 (by-laws). D01–D04 have only 2025 guidance.
- I did not read the packet's question.txt.

readings/gaps:
- **Wrong reading, −$0.10:** using the July 16 range ($5.45) as the "June 30" value because D10 reports the quarter ended June 30. That range was issued after June 30.
- **Wrong reading, −$0.20:** using D08's "$0.20 of dilution" figure. That is roughly the midpoint change (−$0.195), not the low-end move.
- **Wrong reading, $0.00:** treating the April 16 range as the range "on the day of completion". It was issued after March 23.
- **Wrong reading, +$0.07:** comparing April to July ($5.38 → $5.45).
- **Difficulty risk, not a shortcut:** it takes a simple two-document subtraction, and a keyword search for "full-year 2026 adjusted diluted EPS" finds all the inputs. The solver still has to work out which range was in effect on each date.
- **Gap:** there is no packet document between Jan 22 and Apr 16 or between Apr 16 and Jul 16, 2026, such as a press release on the closing day. D08's "Updates Guidance" title and D10's "previous range" wording support the ranges used here, but an outside interim update can't be ruled out.
- **Coverage:** I covered D01–D06 by targeted searches rather than full reads.
- **Contamination:** none observed.

Paths:
- D:\Dev\Docket\tasks\aq-00745\runs\q06-r0-v2-75af3300481645edaf27d664082704af6e30b89f9562705829b7ca01289349f2\shortcut\text\D07.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q06-r0-v2-75af3300481645edaf27d664082704af6e30b89f9562705829b7ca01289349f2\shortcut\text\D08.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q06-r0-v2-75af3300481645edaf27d664082704af6e30b89f9562705829b7ca01289349f2\shortcut\text\D10.txt
